Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer

Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley

How AI and ML Drive iPSC Quality with Aspen Neuroscience's Thorsten Gorba, Ph.D.

Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D.

Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther

What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

Inside CRISPR-GPT with Yuanhao Qu

Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou

FDA Fridays: Advancing Communication and Consistency in CGT Regulation with Kaye Spratt

Navigating the Journey to Safer Stem Cell Therapies with Orca Bio's Nate Fernhoff

Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder

Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.

CRI’s Response to NIH Cuts with Alicia Zhou, Ph.D.

Rethinking CGT Biotech Growth & Investment with Audrey Greenberg